Literature DB >> 22056403

Comprehensive handbook for developing a bladder cancer cystectomy database.

Yair Lotan1, Gilad Amiel, Stephen A Boorjian, Peter E Clark, Michael Droller, Jeffrey R Gingrich, Thomas J Guzzo, Brant A Inman, Ashish M Kamat, Larry Karsh, Matthew E Nielsen, Norm D Smith, Shahrokh F Shariat, Robert S Svatek, Jennifer M Taylor.   

Abstract

OBJECTIVE: In an effort to standardize data collection for research regarding bladder cancer, the Bladder Cancer Working Group sought to provide a handbook that can be used as a guide for prospective or retrospective data collection.
METHODS: Expert opinions for various data groups were compiled through a team of researchers at the BCAN. Peer review of each data group was performed from within the group.
RESULTS: Essential and comprehensive data elements are provided for 9 groups of data elements, including demographics, comorbidities, staging, laboratory data, operative details, pathology, complications, outcomes, and quality of life measurements.
CONCLUSIONS: Establishment of a comprehensive bladder cancer database is important in initiating multicenter collaborations. While not every data point is critical, this review may be useful in serving as a reference in initiating projects and providing a framework for collaborations.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Databases

Mesh:

Year:  2011        PMID: 22056403     DOI: 10.1016/j.urolonc.2011.09.004

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  5 in total

1.  Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLD.

Authors:  Sarah A Gallagher; Angela B Smith; Jonathan E Matthews; Clarence W Potter; Michael E Woods; Mathew Raynor; Eric M Wallen; W Kimryn Rathmell; Young E Whang; William Y Kim; Paul A Godley; Ronald C Chen; Andrew Wang; Chaochen You; Daniel A Barocas; Raj S Pruthi; Matthew E Nielsen; Matthew I Milowsky
Journal:  Urol Oncol       Date:  2013-02-19       Impact factor: 3.498

2.  Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer.

Authors:  S Singer; C Ziegler; T Schwalenberg; A Hinz; H Götze; T Schulte
Journal:  Support Care Cancer       Date:  2012-12-14       Impact factor: 3.603

3.  Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

Authors:  Sam S Chang; Bernard H Bochner; Roger Chou; Robert Dreicer; Ashish M Kamat; Seth P Lerner; Yair Lotan; Joshua J Meeks; Jeff M Michalski; Todd M Morgan; Diane Z Quale; Jonathan E Rosenberg; Anthony L Zietman; Jeffrey M Holzbeierlein
Journal:  J Urol       Date:  2017-04-26       Impact factor: 7.450

4.  Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.

Authors:  Yang Yang; Chuangang Li; Hong Li; Moli Wu; Changle Ren; Yuhong Zhen; Xiaochi Ma; Yunpeng Diao; Xiaodong Ma; Sa Deng; Jia Liu; Xiaohong Shu
Journal:  Oncotarget       Date:  2017-06-20

5.  How to predict the risk of complication or death after radical cystectomy?

Authors:  Antonín Brisuda
Journal:  Cent European J Urol       Date:  2015-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.